ADVERTISEMENT
Digital Pathology
Get real time update about this post category directly on your device, subscribe now.
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality
Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a...
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing
Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop...
HHS Denies Disbandment of CDC Vaccine Advisory Group in Wake of Court Ruling
A spokesperson for the Department of Health and Human Services refuted the claim, made Thursday on social media by ACIP...
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
Suppliers are investing in production to support deals with AstraZeneca, Bayer, and other drugmakers that are advancing radioisotope-based cancer therapies....
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have to Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out...
HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs
As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances...
Splashy Drug Discovery.
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb, and AstraZeneca are all ramping up the use of AI, but drug discovery...
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed...
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with...
Rare diseases – spinal muscular atrophy
Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to...
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with...
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the...
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White...
Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic
Healthcare’s staffing challenge stems from mismatch rather than absolute shortage. Systems should redesign roles, modernise job classes and expand team-based...
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip...
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
Accure to complete required preclinical studies to file IND application for ACT-02 program in 2026 Fonds National de Recherche (FNR) grant will...
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism
Abu Dhabi, United Arab Emirates. February 27, 2025: Cleveland Clinic Abu Dhabi, part of the M42 group, has recorded a...
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital
Questions: Could you please tell us a little bit about yourself and your academic background? I currently serve as Vice-President...
China Urges Fever Clinic Expansion Amid Respiratory Illness Spike
China’s health ministry has called for more fever clinics to address a surge in respiratory illnesses during the country’s first...
“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”
New state–of–the–art MRI machine boosts medical imaging at Saudi German Hospital Dubai MRI services at Saudi German Hospital Dubai have...
Saudi Arabia’s agile auditing and compliance system secures investor confidence
In today's global economy, a country’s ability to attract domestic and foreign investments is key for fostering economic growth, creating...
Pharmacogenomics and genetic diversity: Prospects at a tertiary care center in Saudi Arabia
Pharmacogenomics is the study of how a person’s genetic makeup affects their response (efficacy and safety) to drugs. This field...
“Maximizing Your Chances of Pregnancy: Ovulation Induction Strategies”
Before pregnancy can occur, the egg cell must mature and be released from the ovary to the fallopian tube. This...
In Search Of Game-Changing Technologies At AUTOMA+ 2023
Game-changing industry trends and technologies were discussed at Healthcare Automation and Digitalisation Congress 2023, that was held in Zurich, Switzerland,...
Is cellular immunotherapy the next breakthrough in cancer treatment?
The field is evolving rapidly, with several new therapies set to be approved. Deepa Narwani Over the last few...
